ImpediMed is committed to the objective of promoting investor confidence and the rights of shareholders by:
(a) complying with the continuous disclosure obligations imposed by law;
(b) ensuring that company announcements are presented in a factual, clear and balanced way;
(c) ensuring that all shareholders have equal and timely access to material information concerning the Company; and
(d) communicating effectively with shareholders and making it easy for them to participate in general meetings.